| 1 | Chemotherapy-induced peripheral neuropathy in adults: a comp… (10.2147/cmar.s44261) | Abstract References ORCID | 178.11 | 236 |
| 2 | Malignant bowel obstruction in advanced cancer patients: epi… (10.2147/cmar.s29297) | Abstract References ORCID | 177.97 | 235 |
| 3 | Interstitial fluid flow in cancer: implications for disease… (10.2147/cmar.s65444) | Abstract References ORCID | 175.08 | 215 |
| 4 | Results of a phase I pilot clinical trial examining the effe… (10.2147/cmar.s4544) | Abstract References ORCID | 173.54 | 205 |
| 5 | <p>The Anti-Cancer Mechanisms of Berberine: A Review&l… (10.2147/cmar.s242329) | Abstract References ORCID | 172.25 | 197 |
| 6 | Presentation and management of docetaxel-related adverse eff… (10.2147/cmar.s40601) | Abstract References ORCID | 169.86 | 183 |
| 7 | A review of soft-tissue sarcomas: translation of biological… (10.2147/cmar.s159641) | Abstract References ORCID | 155.67 | 118 |
| 8 | Nedaplatin: a cisplatin derivative in cancer chemotherapy (10.2147/cmar.s35785) | Abstract References ORCID | 155.11 | 116 |
| 9 | <p>The Emerging Roles of miR-125b in Cancers</p> (10.2147/cmar.s232388) | Abstract References ORCID | 151.90 | 105 |
| 10 | Multiple neoplasms, single primaries, and patient survival (10.2147/cmar.s57378) | Abstract References ORCID | 151.90 | 105 |
| 11 | Bone metastasis pattern in initial metastatic breast cancer:… (10.2147/cmar.s155524) | Abstract References ORCID | 151.59 | 104 |
| 12 | <p>miR-600 inhibits lung cancer via downregulating the… (10.2147/cmar.s181058) | Abstract References ORCID | 151.59 | 104 |
| 13 | Anatomy of lymphatic drainage of the esophagus and lymph nod… (10.2147/cmar.s182436) | Abstract References ORCID | 150.65 | 101 |
| 14 | Association between body mass index and breast cancer risk:… (10.2147/cmar.s144619) | Abstract References ORCID | 150.00 | 99 |
| 15 | The role of epithelial&ndash;mesenchymal transition prog… (10.2147/cmar.s35171) | Abstract References ORCID | 150.00 | 99 |
| 16 | CCNA2 acts as a novel biomarker in regulating the growth and… (10.2147/cmar.s176833) | Abstract References ORCID | 148.33 | 94 |
| 17 | <p>Current status and future prospects of PARP inhibit… (10.2147/cmar.s200524) | Abstract References ORCID | 148.33 | 94 |
| 18 | Targeting autophagy in cancer management &ndash; strateg… (10.2147/cmar.s34859) | Abstract References ORCID | 148.33 | 94 |
| 19 | Radium-223 chloride: a potential new treatment for castratio… (10.2147/cmar.s25537) | Abstract References ORCID | 147.28 | 91 |
| 20 | Cancer therapy and cardiovascular risk: focus on bevacizumab (10.2147/cmar.s77400) | Abstract References ORCID | 147.28 | 91 |
| 21 | The clinical use of pretreatment NLR, PLR, and LMR in patien… (10.2147/cmar.s171035) | Abstract References ORCID | 146.93 | 90 |
| 22 | <p>Knockdown of EBV-encoded circRNA circRPMS1 suppress… (10.2147/cmar.s218967) | Abstract References ORCID | 146.57 | 89 |
| 23 | Dexrazoxane for the treatment of chemotherapy-related side e… (10.2147/cmar.s47238) | Abstract References ORCID | 146.20 | 88 |
| 24 | Management of malignant pleural effusion: challenges and sol… (10.2147/cmar.s95663) | Abstract References ORCID | 146.20 | 88 |
| 25 | Atypical teratoid/rhabdoid tumors: challenges and search for… (10.2147/cmar.s83472) | Abstract References ORCID | 145.84 | 87 |
| 26 | <p>Systemic inflammation response index predicts progn… (10.2147/cmar.s186976) | Abstract References ORCID | 145.46 | 86 |
| 27 | <p>Prognostic value of tumor-associated macrophages in… (10.2147/cmar.s196951) | Abstract References ORCID | 145.46 | 86 |
| 28 | Gastric cancer: epidemiology, prevention, classification, an… (10.2147/cmar.s149619) | Abstract References | 145.42 | 809 |
| 29 | MiR-497-5p, miR-195-5p and miR-455-3p function as tumor supp… (10.2147/cmar.s163335) | Abstract References ORCID | 145.09 | 85 |
| 30 | Treatment challenges in the management of relapsed or refrac… (10.2147/cmar.s34273) | Abstract References ORCID | 144.71 | 84 |
| 31 | Advances in antitumor effects of NSAIDs (10.2147/cmar.s175212) | Abstract References ORCID | 144.32 | 83 |
| 32 | <p>Carfilzomib for relapsed and refractory multiple my… (10.2147/cmar.s150653) | Abstract References ORCID | 141.49 | 76 |
| 33 | Importance of tumor size at diagnosis as a prognostic factor… (10.2147/cmar.s177663) | Abstract References ORCID | 141.06 | 75 |
| 34 | <p>CircHIPK3 Promotes Gemcitabine (GEM) Resistance in… (10.2147/cmar.s239326) | Abstract References ORCID | 140.63 | 74 |
| 35 | <p>Low-Concentration PTX And RSL3 Inhibits Tumor Cell… (10.2147/cmar.s217944) | Abstract References ORCID | 139.75 | 72 |
| 36 | <p>LOX-1+ PMN-MDSC enhances immune suppression which p… (10.2147/cmar.s210545) | Abstract References ORCID | 139.30 | 71 |
| 37 | Systemic immune&ndash;inflammation index as a useful pro… (10.2147/cmar.s151026) | Abstract References ORCID | 138.84 | 70 |
| 38 | <p>Circular RNA hsa_circ_0072309 inhibits proliferatio… (10.2147/cmar.s186857) | Abstract References ORCID | 138.84 | 70 |
| 39 | MicroRNA function and dysregulation in bone tumors: the evid… (10.2147/cmar.s53928) | Abstract References ORCID | 138.84 | 70 |
| 40 | Enhanced recovery programs in lung cancer surgery: systemati… (10.2147/cmar.s150500) | Abstract References ORCID | 138.38 | 69 |
| 41 | <p>Clinical utility of pembrolizumab in the management… (10.2147/cmar.s151023) | Abstract References ORCID | 137.91 | 68 |
| 42 | <p>EGFR Promotes the Development of Triple Negative Br… (10.2147/cmar.s225376) | Abstract References ORCID | 137.91 | 68 |
| 43 | <p>High Expression of CD44 Predicts a Poor Prognosis i… (10.2147/cmar.s233423) | Abstract References ORCID | 137.44 | 67 |
| 44 | The tumor microenvironment in prostate cancer: elucidating m… (10.2147/cmar.s32839) | Abstract References ORCID | 136.96 | 66 |
| 45 | CircZNF609 promotes breast cancer cell growth, migration, an… (10.2147/cmar.s174778) | Abstract References ORCID | 136.47 | 65 |
| 46 | <p>Circular RNA circHIPK3 promotes cell proliferation… (10.2147/cmar.s190669) | Abstract References ORCID | 135.97 | 64 |
| 47 | <p>The prognostic value and mechanisms of lncRNA UCA1… (10.2147/cmar.s200436) | Abstract References ORCID | 135.46 | 63 |
| 48 | <p>Cervical Cancer Cells-Secreted Exosomal microRNA-22… (10.2147/cmar.s221527) | Abstract References ORCID | 135.46 | 63 |
| 49 | Trends in clinical features and survival of oral cavity canc… (10.2147/cmar.s171251) | Abstract References ORCID | 134.95 | 62 |
| 50 | <p>Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1,… (10.2147/cmar.s203137) | Abstract References ORCID | 134.95 | 62 |